Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/31/1997 | WO1997049414A1 Manufacturing process for the production of purified transferrin |
12/31/1997 | WO1997049373A2 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
12/31/1997 | WO1997049289A1 Vibrio cholerae having increased sensitivity to antibiotics |
12/31/1997 | WO1997049277A1 DISEASE RESISTANCE IN $i(VITIS) |
12/31/1997 | WO1997045528A3 Mammalian tolloid-like gene and protein |
12/31/1997 | WO1997044469A3 Multiple epitope fusion protein |
12/31/1997 | WO1997044454A3 Human phospholipase inhibitor |
12/31/1997 | WO1997041226A3 Polynucleotides encoding the transcriptional repressor gcf2 of the epidermal growth factor receptor |
12/31/1997 | WO1997035880A3 Polynucleic acid sequences that are functionally associated with the development of autoimmune disease |
12/31/1997 | WO1997035873A3 Peptides with antiproliferative properties |
12/31/1997 | WO1997030159A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
12/31/1997 | CN1169158A Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
12/31/1997 | CN1036850C Novel cell cortex protein |
12/31/1997 | CA2261029A1 Aatt promoter element and transcription factor |
12/31/1997 | CA2259636A1 Process for extracting and purifying recombinant, non-lipidised osp-protein |
12/31/1997 | CA2259390A1 Improved method for the production of soluble collagen |
12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
12/31/1997 | CA2259125A1 Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis |
12/31/1997 | CA2259124A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
12/31/1997 | CA2258961A1 A cell-free system for initiation of dna replication |
12/31/1997 | CA2258871A1 Polypeptides mimicking the activity of human erythropoietin |
12/31/1997 | CA2258576A1 Gene conferring disease resistance in plants and uses thereof |
12/31/1997 | CA2258564A1 Brain glycogen phosphorylase cancer antigen |
12/31/1997 | CA2258265A1 Disease resistance in vitis |
12/31/1997 | CA2258168A1 Recombinant vaccine for diseases caused by encapsulated organisms |
12/31/1997 | CA2257905A1 Genetic control of flowering |
12/31/1997 | CA2257849A1 Glucuronide repressors and uses thereof |
12/31/1997 | CA2254995A1 Cell adhesion inhibiting compounds |
12/31/1997 | CA2230088A1 A novel hypertension related calcium regulated gene (hcarg) |
12/30/1997 | USRE35706 Administering as viricides and antitumor agents |
12/30/1997 | US5703221 Stealth virus nucleic acids and related methods |
12/30/1997 | US5703220 May be used to provide therapeutic vehicles for treatment of processes involving function of melanocortin receptors |
12/30/1997 | US5703219 Hybrids |
12/30/1997 | US5703217 Nucleotide fragment of the 23S ribosomal RNA of mycobacteria, derived probes and primers, reagent and detection method |
12/30/1997 | US5703213 Monoclonal antibodies which recognize an adenocarcinoma cell antigen |
12/30/1997 | US5703212 Preventive for circulatory diseases |
12/30/1997 | US5703209 Purified and isolated polypeptide encoded by nucleic acid sequence of nucleic acid molecule which is fragment of gene encoding amyloid precursor protein isoform |
12/30/1997 | US5703207 Protein active in humoral hypercalcemia of malignancy-PTHrP |
12/30/1997 | US5703206 Macrophage inflammatory protein 2 (MIP-2) |
12/30/1997 | US5703205 Laminin a chain polypeptides from the amino terminal golbular domain |
12/30/1997 | US5703057 Expression library immunization |
12/30/1997 | US5703055 Generation of antibodies through lipid mediated DNA delivery |
12/30/1997 | US5703049 High methionine derivatives of α-hordothionin for pathogen-control |
12/30/1997 | US5703048 Hepatocyte growth factor |
12/30/1997 | US5703046 Treatment method using recombinantly produced human membrane cofactor protein (MCP) |
12/30/1997 | US5703045 Nervous system disorders |
12/30/1997 | US5703044 Plant protein |
12/30/1997 | US5703043 Bone morphogenetic protein-10 (BMP-10) compositions |
12/30/1997 | US5703040 Antimicrobial proteinaceous substances produced by staphylococcus aureus |
12/30/1997 | US5703039 Chimeric toxins |
12/30/1997 | US5703038 Emhanced biological activity |
12/30/1997 | US5702948 Saccular collagen and compositions and methods for making and using the same |
12/30/1997 | US5702934 Processes for producing an enzyme |
12/30/1997 | US5702931 Mutagenic oligonucleotide introduces desired mutation at one site, and at a second site, introduces or eliminates a restriction site, allowing one to screen for desired mutation by restriction analysis |
12/30/1997 | US5702923 Active against bacteria and effective at ph between 2 and 8 |
12/30/1997 | US5702922 Extracting from cells of transformed microorganism using aqueous acid |
12/30/1997 | US5702921 Expression of biologically active human C-reactive protein in escherichia coli |
12/30/1997 | US5702920 Polypeptides |
12/30/1997 | US5702919 DNA encoding canine granulocyte macrophage colony stimulating factor |
12/30/1997 | US5702918 HIV-2 envelope polypeptides |
12/30/1997 | US5702917 Polynucleotides encoding human ICAM-4 |
12/30/1997 | US5702914 Genetic engineering; bioassay |
12/30/1997 | US5702909 Methods of detecting collagen type II degradation in vivo |
12/30/1997 | US5702908 Interruption of binding of MDM2 and p53 protein and therapeutic application thereof |
12/30/1997 | US5702907 Nucleotide sequence |
12/30/1997 | US5702906 Preferentially binds neurotropic factor-4 but does not bind nerve growth factor, brain-derived neurotropic factor, or neuronal factor |
12/30/1997 | US5702904 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
12/30/1997 | US5702903 Detecting gene that has been amplified or detecting increased expression of gene products |
12/30/1997 | US5702902 Using gene transcript |
12/30/1997 | US5702897 Interaction of proteins involved in a cell death pathway |
12/30/1997 | US5702894 Methods of analysis and manipulating of DNA utilizing mismatch repair systems |
12/30/1997 | US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
12/30/1997 | US5702885 Method for HLA typing |
12/30/1997 | US5702883 Methods for detection of mutagens using luminescence gene |
12/30/1997 | US5702708 Salmonicida iron regulated protein and lipopolysaccharide vaccine |
12/30/1997 | US5702707 A polypeptide including amino acid sequence extending from position 92 to 109 of p17 gag protein of hiv-1, total number of amino acid does not exceed about 40; basis for vaccine |
12/30/1997 | US5702705 Antibody methods for the treatment of a hormone-mediated disease |
12/30/1997 | US5702704 Antibodies to in vivo advanced glycosylation endproducts |
12/30/1997 | US5702699 Process for the recovery of lipophilic proteins |
12/30/1997 | US5702698 Promoting production of colony stimulating factor |
12/30/1997 | CA2133850C Process for preparing virus-resistant transgenic plant |
12/30/1997 | CA1339608C Reg gene and protein encoded by the gene |
12/30/1997 | CA1339606C Polypeptides complementary to peptides or proteins having an amino acid sequence or necleotide coding sequence at least partially known |
12/29/1997 | EP0814166A2 Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof |
12/29/1997 | EP0814162A2 Expression of the alpha-toxin gene (hla) of staphylococcus aureus using a chromosomally encoded hla-lacZ gene fusion |
12/29/1997 | EP0814161A1 Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis |
12/29/1997 | EP0814160A2 KEX2 proteinase inhibitor |
12/29/1997 | EP0814159A2 Transgenic non-human animals capable of producing heterologous antibodies |
12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
12/29/1997 | EP0814157A2 Diagnostic marker for variants of presenilin genes associated with Alzheimers Disease and Familial Adult Onset Alzheimers Disease |
12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
12/29/1997 | EP0814090A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection |
12/29/1997 | EP0814089A2 Respiratory syncytial virus: vaccines and diagnostic assays |
12/29/1997 | EP0813683A1 Method for the diagnosis of injections |
12/29/1997 | EP0813682A1 Multiple drug resistance gene of aspergillus fumigatus |
12/29/1997 | EP0813606A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
12/29/1997 | EP0813604A1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
12/29/1997 | EP0813603A1 Expression of gene products from genetically manipulated strains of bordetella |
12/29/1997 | EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
12/29/1997 | EP0813541A1 Process for producing a protein |